Milk thistle shows protective effect against chemo-induced liver inflammation
One of the challenges of chemotherapy is the side effect of liver inflammation, which can necessitate a reduction in dose or even discontinuance of the drug. However, a new study described in an article published online on December 14, 2009 in the American Cancer Society journal Cancer reveals that the herb milk thistle, which contains the liver protective compound silibinin, reduces inflammation of the liver in children receiving treatment for acute lymphoblastic leukemia (ALL).
Extracts of milk thistle have been evaluated for the treatment of liver damage from alcohol and other toxins, yet data concerning the herb's value in chemotherapy-associated liver problems is limited. In a double-blinded trial, Kara Kelly, MD, of the New York-Presbyterian Hospital/Columbia University Medical Center’s Herbert Irving Comprehensive Cancer Center and her colleagues randomized 50 children with inflammation of the liver due to chemotherapy for ALL to receive a placebo or an extract containing one part silibinin to two parts phosphatidylcholine (a nutrient that improves silibinin's bioavailability) for 28 days. Each capsule contained 80 milligrams silibinin, and the number of capsules administered was determined by the patient's weight. The liver enzymes aspartate amino transferase (AST) and amino alanine transferase (ALT) were measured at the beginning of the study, at the end of the treatment period and one month following the end of treatment.
While no significant changes in liver enzymes were observed immediately following treatment, total bilirubin levels were lower by 50 percent in 5 patients who received milk thistle and none of the placebo group. One month after treatment, the enzyme AST was significantly lower in children who received milk thistle and a trend toward lower ALT levels than those measured at baseline was observed compared to the placebo group. The authors attribute the late response to delayed effects, inadequate dosing or short duration of supplementation.
The need to reduce chemotherapy due to liver toxicity was less in patients who received milk thistle compared to those who received a placebo, although the difference was not considered significant according to the authors. In laboratory tests, milk thistle was demonstrated not to interfere with chemotherapy's anticancer effect.
The study is the first randomized, controlled clinical trial to investigate the feasibility and safety of milk thistle in combination with chemotherapy for children being treated for cancer. "Milk thistle needs to be studied further, to see how effective it is for a longer course of treatment, and whether it works well in reducing liver inflammation in other types of cancers and with other types of chemotherapy," Dr Kelly stated. "However, our results are promising as there are no substitute medications for treating liver toxicity."
According to the National Cancer Institute, almost all normal cells grow and die in a controlled way through a process called apoptosis. Cancer cells, on the other hand, keep dividing and forming more cells without a control mechanism to induce normal apoptosis.
Anticancer drugs destroy cancer cells by stopping them from growing or dividing at one or more points in their growth cycle. Chemotherapy may consist of one or several cytotoxic drugs that kill cells by one or more mechanisms. The chemotherapy regimen chosen by most conventional oncologists is based on the type of cancer being treated. There are factors other than the type of cancer that can be used to determine the ideal chemotherapy drugs that should be used to treat an individual patient.
The goal of chemotherapy is to shrink primary tumors, slow the tumor growth, and kill cancer cells that may have spread (metastasized) to other parts of the body from the original, primary tumor. However, chemotherapy kills both cancer cells and healthy normal cells. Oncologists try to minimize damage to normal cells and to enhance the cell killing (cytotoxic) effect on cancer cells. Too often, unfortunately, this delicate balance is not achieved.
Clinical studies show that for certain types of cancer chemotherapy prolongs survival and increases the percentage of patients achieving a remission. A partial remission is defined as 50% or greater reduction in the measurable parameters of tumor growth as may be found on physical examination, radiologic study, or by biomarker levels from a blood or urine test. A complete remission is defined as complete disappearance of all such manifestations of disease. The goal of all oncologists is to strive for a complete remission that lasts a long time--a durable complete remission, or CR. Unfortunately; the vast majority of remissions that are achieved are partial remissions. Too often, these are measured in weeks to months and not in years. Some types of cancer do not show any meaningful response to chemotherapy.
Bilberry Extract Capsules
Certain age-related problems common to the eyes are often caused by a breakdown of the circulatory system of the eye. Bilberry extracts have an antioxidative property that helps suppress photo-oxidative processes and have been shown to improve microcapillary circulation. The anthocyanoside content of bilberry may be especially beneficial for nighttime visual acuity.
Magnesium is one of the body’s most important minerals. It is required as a co-factor in hundreds of enzymatic processes within cells. It helps maintain normal muscle and nerve function, keeps heart rhythm steady, promotes a healthy cardiovascular function, supports a healthy immune system, and keeps bones strong. Magnesium also helps maintain blood sugar and blood pressure levels already within normal range, and it is known to be involved in energy metabolism and protein synthesis.